MedTrace Logo

Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

NCT03089125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 247

Last updated 2025-02-27

Study results available
· View outcomes & findings →

Summary

This research study is evaluating a behavioral intervention designed to help people with advanced lung cancer manage dyspnea (i.e., breathlessness or shortness-of-breath).

Conditions

Interventions

BEHAVIORAL

Dyspnea Intervention

Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness

OTHER

Usual Care

Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Dana-Farber Cancer Institute

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Joseph Greer, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2022-10-26
Completion
2023-04-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03089125 on ClinicalTrials.gov